Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71851 - 71875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	NIPAL2	79815	downregulated	Silicon Dioxide results in decreased expression of NIPAL2 mRNA	8q22.2	A24196
Silicon dioxide	Approved	NIPAL3	57185	downregulated	Silicon Dioxide analog results in decreased expression of NIPAL3 mRNA	1p36.11	A24195
Silicon dioxide	Approved	NIPSNAP3B	55335	downregulated	Silicon Dioxide analog results in decreased expression of NIPSNAP3B mRNA	9q31.1	A24195
Silicon dioxide	Approved	NKD1	85407	downregulated	Silicon Dioxide analog results in decreased expression of NKD1 mRNA	16q12.1	A24195
Silicon dioxide	Approved	NKD2	85409	upregulated	Silicon Dioxide analog results in increased expression of NKD2 mRNA	5p15.33	A24194 A24195
Silicon dioxide	Approved	NKX3-1	4824	downregulated	Silicon Dioxide results in decreased expression of NKX3-1 mRNA	8p21.2	A24196
Silicon dioxide	Approved	NKX3-2	579	downregulated	Silicon Dioxide analog results in decreased expression of NKX3-2 mRNA	4p15.33	A24195
Silicon dioxide	Approved	NKX6-2	84504	upregulated	Silicon Dioxide analog results in increased expression of NKX6-2 mRNA	10q26.3	A24194
Silicon dioxide	Approved	NLE1	54475	upregulated	Silicon Dioxide analog results in increased expression of NLE1 mRNA	17q12	A24195
Silicon dioxide	Approved	NLGN4Y	22829	downregulated	Silicon Dioxide analog results in decreased expression of NLGN4Y mRNA	Yq11.221	A24195
Silicon dioxide	Approved	NLGN4Y	22829	upregulated	Silicon Dioxide analog results in increased expression of NLGN4Y mRNA	Yq11.221	A24194
Silicon dioxide	Approved	NLRC3	197358	upregulated	Silicon Dioxide analog results in increased expression of NLRC3 mRNA	16p13.3	A24194
Silicon dioxide	Approved	NLRP12	91662	downregulated	Silicon Dioxide analog results in decreased expression of NLRP12 mRNA	19q13.42	A24194
Silicon dioxide	Approved	NLRP6	171389	downregulated	Silicon Dioxide analog results in decreased expression of NLRP6 mRNA	11p15.5	A24195
Silicon dioxide	Approved	NMD3	51068	upregulated	Silicon Dioxide analog results in increased expression of NMD3 mRNA	3q26.1	A24195
Silicon dioxide	Approved	NME7	29922	upregulated	Silicon Dioxide results in increased expression of NME7 mRNA	1q24.2	A24196
Silicon dioxide	Approved	NMNAT2	23057	downregulated	Silicon Dioxide analog results in decreased expression of NMNAT2 mRNA	1q25.3	A24195
Silicon dioxide	Approved	NMRK1	54981	downregulated	Silicon Dioxide analog results in decreased expression of NMRK1 mRNA	9q21.13	A24195
Silicon dioxide	Approved	NMRK1	54981	downregulated	Silicon Dioxide results in decreased expression of NMRK1 mRNA	9q21.13	A24196
Silicon dioxide	Approved	NMT1	4836	upregulated	Silicon Dioxide results in increased expression of NMT1 mRNA	17q21.31	A24196
Silicon dioxide	Approved	NMT2	9397	upregulated	Silicon Dioxide analog results in increased expression of NMT2 mRNA	10p13	A24195
Silicon dioxide	Approved	NMT2	9397	upregulated	Silicon Dioxide results in increased expression of NMT2 mRNA	10p13	A24196
Silicon dioxide	Approved	NMU	10874	downregulated	Silicon Dioxide analog results in decreased expression of NMU mRNA	4q12	A24195
Silicon dioxide	Approved	NNT	23530	downregulated	Silicon Dioxide results in decreased expression of NNT mRNA	5p12	A24196
Silicon dioxide	Approved	NOC2L	26155	upregulated	Silicon Dioxide analog results in increased expression of NOC2L mRNA	1p36.33	A24195

Displaying entries 71851 - 71875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability